Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.
SJR 25 establishes a temporary 15-member commission to study how hospitals in New Jersey and other states handle patient aftercare following naloxone (opioid antidote) administration. The commission will evaluate current hospital release procedures for these patients and recommend consistent, recovery-focused protocols for statewide implementation. It includes state health officials, hospital association leaders, and public members with expertise in addiction treatment or lived experience. The commission must submit its findings and recommendations to the Governor and Legislature within one year, after which it will expire. This resolution does not enact new laws but creates a study group to inform future policy.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024
Last action Jan 9, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Bob Singer
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SJR 25
Scope: NJ
Hi! I can help you understand SJR 25. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline